• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T; TEST, HIV DETECTION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T; TEST, HIV DETECTION Back to Search Results
Catalog Number 7D2648
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/12/2023
Event Type  malfunction  
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 213565 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 7d2648/ lot 213565, test base part number 10732998/ lot 208366.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 213565 showed that the complaint rate is (b)(4).In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue.However, a possible assignable root cause is sample interference or cross contamination.H3 other text : device discarded; single-use device.
 
Event Description
The customer reported three (3) false negative results with the alere determine hiv 1/2 ag/ab for multiple tests performed from 11mar2023 to 13mar2023.This mfr.Report addresses test three (3) of three (3).The customer reported a false negative result with alere determine hiv 1/2 ag/ab performed on (b)(6) 2023.Repeat testing was performed on (b)(6) 2023 and generated negative results.Confirmatory testing was sent to quest diagnostics on (b)(6) 2023 to confirm hiv results.Results are unknown.Additional testing with siemens atellica (reactive combo) hiv was performed on (b)(6) 2023 and (b)(6) 2023 which generated positive results.The customer confirmed there was no patient harm due to the test results.Additionally, the customer confirmed there was no delay or impact in the patient's treatment.
 
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 213565 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 7d2648/ lot 213565, test base part number 10732998/ lot 208366.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 213565 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue.H10 h3 other text : device discarded; single-use device.
 
Event Description
The customer reported three (3) false negative results with the alere determine hiv 1/2 ag/ab for multiple tests performed from (b)(6) 2023 to (b)(6) 2023.This mfr.Report addresses test three (3) of three (3).The customer reported a false negative result with alere determine hiv 1/2 ag/ab performed on (b)(6) 2023.Repeat testing was performed on (b)(6) 2023 and (b)(6) 2023 and generated negative results.Confirmatory testing was sent to quest diagnostics on (b)(6) 2023 to confirm hiv results.Results are unknown.Additional testing with siemens atellica (reactive combo) hiv was performed on (b)(6) 2023 and (b)(6) 2023 which generated positive results.The customer confirmed there was no patient harm due to the test results.Additionally, the customer confirmed there was no delay or impact in the patient's treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALERE DETERMINE HIV 1/2 AG/AB COMBO 25T
Type of Device
TEST, HIV DETECTION
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key17391505
MDR Text Key320318607
Report Number1221359-2023-01289
Device Sequence Number1
Product Code MZF
UDI-Device Identifier00811877011101
UDI-Public00811877011101
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP120037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number7D2648
Device Lot Number213565
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age65 YR
Patient SexMale
Patient Weight81 KG
-
-